Network: Pvi, Peerview Institute For Medical Education
Show Impressions
Estimates only, not verified by show
Est. Podcast Downloads
200
Unlock show and brand data, including top ads, overall spend, and the ability to listen to ads.
Direct Response
Brands with CTAs
20%
Host Read %
% of host read ads
30%
Unlock show and brand data, including top ads, overall spend, and the ability to listen to ads.
The Bottom Line
This show has an estimated 200 audience size, runs 30% host read ads and promotes 20% of ads for direct response advertisers.
| Advertisers | Week4/13 | Week4/20 | Week4/27 | Week5/4 | Week5/11 | Week5/18 | Week5/25 | Week6/1 | Week6/8 | Week6/15 | Week6/22 | Week6/29 | Week7/6 | Week7/13 | Week7/20 | Week7/27 | Week8/3 | Week8/10 | Week8/17 | Week8/24 | Week8/31 | Week9/7 | Week9/14 | Week9/21 | Week9/28 | Week10/5 | Week10/12 | Week10/19 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 AbbVieabbvie.com | AbbVie | 1 | Test in progress 8% | |||||||||||||||||||||||||||
 Daiichi Sankyo Inc.daiichisankyo.com | Daiichi Sankyo Inc. | 1 | Test in progress 8% | |||||||||||||||||||||||||||
National Ovarian Cancer Coalitionovarian.org | National Ovarian Cancer Coalition | 1 | Test in progress 8% |
Unlock show and brand data, including top ads, overall spend, and the ability to listen to ads.
Fans by country:
Unlock show and brand data, including top ads, overall spend, and the ability to listen to ads.
Top Spenders | Est. Spent | Change | Host Read % | DR % | # of ads | Frequency | Top Shows |
|---|---|---|---|---|---|---|---|
Daiichi Sankyo Inc. pharmaceuticals | $4 | 0.0% | 0% | 0% | 2.0ad units | Test run |  +1 |
 PeerView e-learning | $4 | 0.0% | 50% | 100% | 2.0ad units | Test run |   +1 |
Four-Way Cold Tablets | $3 | 0.0% | 0% | 0% | 1.0ad units | Test run |   +1 |
Unlock show and brand data, including top ads, overall spend, and the ability to listen to ads.
William G. Wierda, MD, PhD - C3–Changing Conversations on CLL: Evidence and Emerging Consensus on Targeted Agents Across Lines of Therapy
0:00 / 0:26#1
Run on 1x episodeUnlock show and brand data, including top ads, overall spend, and the ability to listen to ads.